Figure 5.
Figure 5. FTY720 treatment inhibits GC formation in the peripheral lymphoid tissues. (A) Spleen, LNs, and PPs from immunized mice treated with water or FTY720 were analyzed for GL7+Fas+ GC B cells by flow cytometry. Cells were stained with GL-7-FITC and anti-Fas-phycoerythrin (PE) (PharMingen). The numbers shown represent percentages of GL-7+Fas+ GC B cells within the lymphocyte gate. (B) In situ GC formation was evaluated by immunohistologic staining. GL-7 and anti-B220 monoclonal antibodies were used to label all B cells (blue) and GC B cells (red), respectively. Original magnification × 50. Similar results were obtained from 3 independent experiments with 3 to 5 mice per group.

FTY720 treatment inhibits GC formation in the peripheral lymphoid tissues. (A) Spleen, LNs, and PPs from immunized mice treated with water or FTY720 were analyzed for GL7+Fas+ GC B cells by flow cytometry. Cells were stained with GL-7-FITC and anti-Fas-phycoerythrin (PE) (PharMingen). The numbers shown represent percentages of GL-7+Fas+ GC B cells within the lymphocyte gate. (B) In situ GC formation was evaluated by immunohistologic staining. GL-7 and anti-B220 monoclonal antibodies were used to label all B cells (blue) and GC B cells (red), respectively. Original magnification × 50. Similar results were obtained from 3 independent experiments with 3 to 5 mice per group.

Close Modal

or Create an Account

Close Modal
Close Modal